Clinical outcomes and prognostic factors for patients with Vibrio vulnificus infections requiring intensive care: A 10-yr retrospective study

被引:34
作者
Chen, Shiuan-Chih [1 ,2 ,4 ,6 ]
Chan, Khee-Siang [2 ,9 ]
Chao, Wai-Nang [8 ]
Wang, Po-Hui [1 ]
Lin, Ding-Bang [3 ,7 ]
Ueng, Kwo-Chang [1 ,2 ,5 ]
Kuo, Sheng-Hung [2 ,10 ]
Chen, Chun-Chieh [1 ,4 ,6 ]
Lee, Meng-Chih [2 ,4 ]
机构
[1] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[2] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[3] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan
[5] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Occupat Med, Taichung, Taiwan
[7] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan
[8] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan
[9] Chi Mei Med Ctr, Intens Care Unit, Tainan, Taiwan
[10] Yuan Lin Kuo Hosp, Dept Surg, Changhua, Taiwan
关键词
Vibrio vulnificus; prognostic factor; intensive care; Acute Physiology and Chronic Health Evaluation; mortality; SOFT-TISSUE INFECTIONS; IN-VITRO; MARINE VIBRIO; GULF-COAST; APACHE-II; BLOOD; CLASSIFICATION; EPIDEMIOLOGY; MINOCYCLINE; CEFOTAXIME;
D O I
10.1097/CCM.0b013e3181eeda2c
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Vibrio vulnificus infection is uncommon but potentially life-threatening. The aim of this study was to evaluate clinical outcomes and prognostic factors for patients with V. vulnificus infections admitted to an intensive care unit. Design: Retrospective study. Setting: Multidisciplinary intensive care unit in a 2300-bed teaching hospital. Patients: Eighty-five adult patients (>= 18 yrs) with V. vulnificus infections who required intensive care were enrolled and reviewed during a 10-yr period. Interventions: None. Measurements and Main Results: Thirty-four of the 85 patients died, giving an intensive care unit mortality rate of 40%. The mean Acute Physiology and Chronic Health Evaluation II score on intensive care unit admission was 18.4 (95% confidence interval, 17.1-19.8). The most common underlying disease was hepatic disease (48%) followed by diabetes mellitus (22%). Multivariate analysis showed that risk factors for intensive care unit mortality were the presence of hemorrhagic bullous skin lesions/necrotizing fasciitis (relative risk, 2.4; 95% confidence interval, 1.3-4.5; p = .006), skin/soft tissue infections involving two or more limbs (relative risk, 2.5; 95% confidence interval, 1.1-5.7; p = .025), and higher Acute Physiology and Chronic Health Evaluation II scores on intensive care unit admission (relative risk, 1.2; 95% confidence interval, 1.1-1.3; p = .0001). In contrast, surgical treatment <24 hrs after arrival was inversely associated with intensive care unit mortality (relative risk, 0.35; 95% confidence interval, 0.15-0.79; p = .012). In addition, the area under the receiver operating characteristic curve for Acute Physiology and Chronic Health Evaluation II for predicting intensive care unit mortality was 0.945 (95% confidence interval, 0.873-0.983; p = .0001). An optimal cutoff Acute Physiology and Chronic Health Evaluation II score of >= 20 had a sensitivity of 97% and a specificity of 86% with a 41.4-fold increased risk of fatality (p = .0003). Conclusions: This study found that V. vulnificus-infected patients with hemorrhagic bullous skin lesions/necrotizing fasciitis, skin/soft tissue infections involving two or more limbs, or higher Acute Physiology and Chronic Health Evaluation II scores have high risks of intensive care unit mortality. However, patients receiving prompt surgical treatments within 24 hrs after admission have better prognoses. (Crit Care Med 2010; 38: 1984-1990)
引用
收藏
页码:1984 / 1990
页数:7
相关论文
共 42 条
[1]  
Abbott SL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P723
[2]   Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity [J].
Biosca, EG ;
Amaro, C .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1996, 62 (07) :2331-2337
[3]   DISEASE CAUSED BY A MARINE VIBRIO - CLINICAL CHARACTERISTICS AND EPIDEMIOLOGY [J].
BLAKE, PA ;
MERSON, MH ;
WEAVER, RE ;
HOLLIS, DG ;
HEUBLEIN, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (01) :1-5
[4]  
BOWDRE JH, 1983, J PHARMACOL EXP THER, V225, P595
[5]  
Chiang Shyh-Ren, 2003, Journal of Microbiology Immunology and Infection, V36, P81
[6]   VIBRIO-VULNIFICUS INFECTION [J].
CHUANG, YC ;
YOUNG, CD ;
CHEN, CW .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (06) :721-726
[7]   Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection [J].
Chuang, YC ;
Ko, WC ;
Wang, ST ;
Liu, JW ;
Ku, CF ;
Wu, JJ ;
Huang, KY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1319-1322
[8]   VIBRIO-VULNIFICUS INFECTION IN TAIWAN - REPORT OF 28 CASES AND REVIEW OF CLINICAL MANIFESTATIONS AND TREATMENT [J].
CHUANG, YC ;
YUAN, CY ;
LIU, CY ;
LAN, CK ;
HUANG, AHM .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (02) :271-276
[9]   In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus [J].
Chuang, YC ;
Liu, JW ;
Ko, WC ;
Lin, KY ;
Wu, JJ ;
Huang, KY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2214-2217
[10]   Cutaneous injury and Vibrio vulnificus infection [J].
Chung, P. H. ;
Chuang, S. K. ;
Tsang, Thomas ;
Lai Wai-Man ;
Yung, Raymond ;
Lo, Janice .
EMERGING INFECTIOUS DISEASES, 2006, 12 (08) :1302-1303